Loading...
Clinical Research Consent Writer - Center for Cancer Therapeutic Innovation
Dana-Farber Cancer Institute
The Clinical Research Consent Writer is responsible for overseeing the authoring, development and overall quality assurance of the disease group’s consent documents submitted as part of the New Protocol Applications and any required consent amendments. This position will be the primary point person responsible for the collaboration / navigation with the DFCI IRB contacts, clinical trial sponsors, DFCI designated Principal Investigator and the disease group Clinical Research Manager to facilitate and streamline consent development within established timelines. This position will report directly the group’s Clinical Research Regulatory Manager.
Located in Boston and the surrounding communities, Dana-Farber Cancer Institute brings together world renowned clinicians, innovative researchers and dedicated professionals, allies in the common mission of conquering cancer, HIV/AIDS and related diseases. Combining extremely talented people with the best technologies in a genuinely positive environment, we provide compassionate and comprehensive care to patients of all ages; we conduct research that advances treatment; we educate tomorrow's physician/researchers; we reach out to underserved members of our community; and we work with amazing partners, including other Harvard Medical School-affiliated hospitals. Dana-Farber Cancer Institute is an equal opportunity employer and affirms the right of every qualified applicant to receive consideration for employment without regard to race, color, religion, sex, gender identity or expression, national origin, sexual orientation, genetic information, disability, age, ancestry, military service, protected veteran status, or other groups as protected by law.
|
Error
